Welcome to our dedicated page for BrightSpring Health Services SEC filings (Ticker: BTSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Pharmacy reimbursement shifts, multi-state Medicaid rules, and hospice occupancy metrics all live inside BrightSpring Health Services’ dense disclosures. If you’ve ever opened the annual report searching for segment profit only to meet 300 pages of jargon, you know the challenge. BrightSpring’s integrated pharmacy and provider model produces footnote-heavy numbers tying drug dispensing to home health visits—hard to trace in a hurry. Stock Titan surfaces what matters, turning complex paragraphs into clear sentences—BrightSpring Health Services SEC filings explained simply.
Whether you need the BrightSpring Health Services quarterly earnings report 10-Q filing or want BrightSpring Health Services insider trading Form 4 transactions, every document appears here the moment EDGAR posts. Our AI parses each form and delivers:
- Instant red-flag summaries for BrightSpring Health Services 8-K material events explained
- Segment revenue trends from the BrightSpring Health Services earnings report filing analysis
- Real-time alerts for BrightSpring Health Services Form 4 insider transactions real-time, including option grants and dispositions
- A straightforward view of the BrightSpring Health Services proxy statement executive compensation
Ask naturally—“How do I read the BrightSpring Health Services annual report 10-K simplified?” or “Where can I track BrightSpring Health Services executive stock transactions Form 4?”—and our engine delivers. From understanding BrightSpring Health Services SEC documents with AI to comparing pharmacy margins quarter over quarter, you get complete coverage, real-time filing updates, and AI-powered context that helps professionals evaluate risk, model cash flows, and monitor compliance with confidence.
BrightSpring Health Services (BTSG) reported an amended Form 4 reflecting a tax withholding adjustment by its Chairman, President and Chief Executive Officer. On 10/25/2025, 58,746 shares of common stock were withheld under transaction code F at $33.53 per share to cover taxes related to equity vesting.
Following the transaction, the reporting person beneficially owns 1,073,184 shares directly and 369,763 shares indirectly through the Rousseau Family Trust. The filer disclaims beneficial ownership of indirectly held shares except to the extent of any pecuniary interest. The amendment updates the previously filed 10/28/2025 report to reflect the additional shares withheld for taxes.
BrightSpring Health Services (BTSG) director reported a Form 4 transaction. The filing shows a Code F tax withholding of 4,497 shares at $32.68 on November 5, 2025.
According to the explanation, the shares were withheld to cover taxes upon the vesting of 10,708 restricted stock units at a net settlement price equal to the closing stock price on that date. Following the transaction, the director beneficially owns 18,123 shares, held directly. This reflects an administrative withholding tied to RSU vesting rather than an open-market sale.
BrightSpring Health Services (BTSG) reported an insider equity transaction by its Chairman, President and CEO. On 10/25/2025, a Code F event reflected 49,796 shares of common stock withheld to cover taxes at $33.53, tied to the vesting of 109,442 RSUs (net settled at the 10/24/2025 close). After the transaction, the reporting person beneficially owns 1,082,134 shares directly and 369,763 shares indirectly through the Rousseau Family Trust.
BrightSpring Health Services (BTSG) reported strong Q3 2025 results. Total revenue rose to $3.334 billion from $2.601 billion a year ago, led by Products at $2.967 billion and Services at $367.1 million. Gross profit was $392.0 million and operating income increased to $87.8 million from $29.1 million.
Net income was $55.2 million versus a $9.0 million loss last year; diluted EPS was $0.26 compared with a $0.04 loss. Year-to-date operating cash flow reached $258.6 million. Cash and cash equivalents were $140.3 million, and long-term debt (net of current portion) was $2.465 billion.
The Community Living business is classified as discontinued operations and contributed $17.8 million of income in Q3. The company agreed to sell this business for $835.0 million in cash, with closing expected in the first fiscal quarter of 2026, subject to approvals. In October, selling stockholders completed a 15,000,000-share secondary offering; the company concurrently purchased 1,500,000 of those shares at the underwriter’s purchase price.
BrightSpring Health Services, Inc. furnished an 8-K to announce it issued a press release with financial results for the quarter ended September 30, 2025. The press release, dated October 28, 2025, is included as Exhibit 99.1.
The company states the information under Item 2.02, including Exhibit 99.1, is furnished and not deemed “filed” under Section 18 of the Exchange Act, and will only be incorporated by reference if expressly stated.
KKR-affiliated reporting persons filed a Form 4 for BrightSpring Health Services, Inc. (BTSG) reflecting a large secondary sale and related donations. On 10/22/2025, KKR Phoenix Aggregator L.P. sold 14,745,000 shares of BTSG common stock in an underwritten public offering at a net price of $28.782 per share.
Following the sale, beneficial ownership was 62,351,337 shares, then 61,942,032 shares after in-kind distributions of 409,305 shares for charitable donations. Separate gifts included 50,484 shares by Henry R. Kravis and 39,493 shares by George R. Roberts. The filing states ownership is held indirectly through KKR entities, and each reporting person disclaims beneficial ownership except to the extent of any pecuniary interest.
BrightSpring Health Services (BTSG): Insider Form 4 reports major shareholder transactions. Reporting persons affiliated with KKR disclosed the sale of 14,745,000 shares of common stock on 10/22/2025 in an underwritten public offering at a net price of $28.782 per share. Following the sale, beneficially owned shares were 62,351,337 on an indirect basis.
An additional entry reflects 409,305 shares classified under code J as in-kind distributions to partners and shareholders to facilitate charitable donations, leaving 61,942,032 shares beneficially owned indirectly. Separate bona fide gifts (code G) were reported for 50,484 shares by Mr. Kravis and 39,493 shares by Mr. Roberts. The filing notes indirect ownership through KKR Phoenix Aggregator L.P. and customary beneficial ownership disclaimers.
BrightSpring Health Services (BTSG) reported an insider transaction by its Chairman, President and CEO. On October 22, 2025, the reporting person exercised 235,000 stock options at $6.37 and sold 235,000 common shares at $28.782 pursuant to a registered public offering.
Following the transactions, direct ownership stands at 1,131,930 common shares. The filing also lists 369,763 shares held indirectly by the Rousseau Family Trust. Remaining option holdings include 560,241 options (direct) and indirect options of 534,676 (by The Margaret Rousseau Children Trust) and 377,602 (by the Rousseau Family Trust), each with a $6.37 exercise price and 10/16/2029 expiration. The options are noted as fully vested.
BrightSpring Health Services (BTSG) reported an insider transaction by its Chief of Staff and SVP, Human Resources. On October 22, 2025, the officer exercised 20,000 stock options at $6.37 per share and sold 20,000 common shares at $28.782 pursuant to a registered public offering that closed the same day.
Following these transactions, the officer directly beneficially owned 131,150 common shares. Derivative holdings listed included 71,578 stock options remaining beneficially owned. The filing notes the options are fully vested.
BrightSpring Health Services (BTSG) disclosed an underwritten secondary offering of 15,000,000 shares of common stock by selling stockholders, including KKR Phoenix Aggregator L.P., under an automatic shelf on Form S-3ASR. The closing of the offering and related share repurchase occurred on October 22, 2025.
The Company did not receive proceeds from the offering, other than cash received from Management Selling Stockholders’ stock option exercises in connection with the transaction. BrightSpring repurchased 1,500,000 shares from the underwriter as part of the offering, and the underwriter did not receive underwriting fees on the repurchased shares. The underwriting agreement includes customary representations, conditions, and indemnification provisions.